Indian share markets continued to trade flat
with negative bias in the afternoon session amid mixed international markets.
At the closing bell, the BSE Sensex stood lower
by 67 points, while the NSE Nifty finished down by 22 points. Meanwhile, the S&P
BSE Mid Cap & the S&P BSE Small Cap finished down by 1.4% and 0.9%
respectively. Losses were largely seen in pharma, banking and PSU stocks.
Asian shares traded mostly higher with the
exception of China and Hong Kong as continued capital outflows from the country
weighed on sentiment. Japan’s Nikkei 225 gained 0.53% after the Bank of Japan
kept monetary policy steady and offered a brighter view of the economy.
While,
the Shanghai Composite & the Hang Seng fell 0.49% and 0.47% respectively. European
markets are mixed. The CAC 40 is higher by 0.20%, while the FTSE 100 & the DAX
are down 0.21% and 0.06% respectively.
The rupee was trading at 67.90 against the US$ in the afternoon session. Oil prices were trading at US$ 53.23 at the time of writing.
According to a leading financial daily, Glenmark
Pharmaceuticals is planning to spend US$ 100 million each over the three years
period towards capital expenditure. The company plans to expand
existing units and increase their footprints in the global market.
Glenmark Pharma’s share price finished the trading day down by 0.6% on the BSE.
In another development, according to an
article in Livemint, sales of consumer durables and appliances have declined around
40% since the government withdrew Rs 500 and Rs 1000 banknotes on 9 November.
Leading consumer goods firms have postponed new launches and stalled or slashed
expenditure on marketing in the December quarter.
Read the complete Indian stock market update. For terms of use, go here.
No comments:
Post a Comment